DNA Funded vs Elite Trader Funding (2026) — Which Is Better?

Snapshot

DNA Funded and Elite Trader Funding represent two distinct philosophies in the prop trading space. DNA Funded, launched in 2024 by an ASIC-regulated Australian broker, prioritizes multi-asset trading with CFDs, forex, and spot crypto across flexible challenge formats. Elite Trader Funding is a futures-exclusive operation that emphasizes rapid capital access and aggressive profit-sharing on initial gains. The choice between them hinges on your primary trading instruments and how quickly you need to reach funded status.

The Real Bill

DNA Funded costs $49/month with no activation fees—this is your only ongoing cost once you hold a challenge account. Elite Trader Funding charges $75/month base, but adds a critical $80/month activation fee once you reach funded status, pushing total monthly costs to $155 for funded traders. Elite offers frequent promotional discounts (50–90% off evaluation fees), which can make initial challenge costs attractive, but those discounts don't apply to the base $75/month subscription or the $80 activation fee.

The effective cost differential widens significantly once you're funded. A DNA Funded trader pays $49/month indefinitely. An Elite Trader Funding trader pays $155/month indefinitely—over three times more. Even with Elite's promotional entry discounts, the ongoing cost advantage belongs entirely to DNA. For a trader planning a 12-month engagement, DNA Funded costs $588 total; Elite Trader Funding costs $900, despite promotional discounts on the initial challenge. DNA's $50 challenge fee is also refunded upon your first payout, further tilting the economics in its favor.

Feature Deep-Dive

Profit Splits: Elite Trader Funding takes this round with 100% profit splits on the first $12,500 in lifetime sim-funded profits—a genuine structural advantage that lets traders keep every dollar initially earned. DNA Funded offers 80% splits across all profit, which is industry-standard but less generous than Elite's tier. However, DNA's 80% rate applies consistently to accounts of any size, while Elite's 100% tier is capped and declining.

Asset Class Coverage: DNA Funded dominates here. You access 800+ CFD instruments, forex, and spot crypto (with some Rapid challenge restrictions). Elite Trader Funding is futures-only—no forex, equities, options, or crypto. For multi-market traders or anyone wanting portfolio diversification within a single funded account, DNA is the only viable option.

Challenge Structure and Flexibility: Elite Trader Funding offers six evaluation types, which sounds flexible, but all are futures-focused variants. DNA Funded's four challenge types (1-Phase, 2-Phase, Rapid, Instant) serve broader asset traders better. Critically, DNA has no time limits on standard 1-Phase and 2-Phase challenges, while Elite's opaque "LIVE ELITE" invitation criteria and maximum of five active sim-funded accounts (down from 20 in September 2025) suggest tightening restrictions. This is a red flag for Elite—platform constraints are being imposed.

Funding Speed: Both claim same-day funding options. Elite highlights "Fast Track" and "Direct to Funded" pathways and news trading allowances without minimum trading days on select plans, which is genuinely useful for scalpers. DNA does not explicitly mention news trading rules or trading day minimums, suggesting more lenient restrictions.

Broker Integration and Trading Conditions: DNA Funded provides raw spreads from 0.0 pips via TradeLocker with 800+ instruments—exceptional execution conditions. Elite's futures execution is not detailed in available specs, but futures trading inherently has different microstructure than forex. DNA's ASIC-regulated broker backing (DNA Markets) adds legitimacy that Elite lacks—an important distinction in a regulatory grey area.

Account Size and Scaling: Elite offers accounts up to $300K, which is larger than most prop firms. DNA's maximum account size is not specified, suggesting it may be lower. For traders seeking six-figure funded accounts, Elite has a structural advantage, but this only matters if you can pass their evaluation consistently.

Who Should Choose DNA Funded

- Multi-asset traders. If you trade forex, CFDs, indices, commodities, and crypto within the same account strategy, DNA is non-negotiable. Elite's futures-only model forces you to compartmentalize trading across multiple brokers.

- Cost-conscious traders. At $49/month base with no activation fees, DNA costs roughly $900/year less than Elite for funded traders. This margin compounds over years.

- Risk-averse traders prioritizing broker legitimacy. DNA's ASIC regulation through DNA Markets broker provides legal recourse and custody security that unregulated prop platforms cannot match. If regulatory confidence matters to you, DNA is the safer choice.

- Traders wanting zero time pressure. DNA's unlimited challenge timelines mean you can trade at your own pace on standard evaluations. Elite's restrictions (maximum five active accounts, undisclosed LIVE ELITE criteria) suggest you're on borrowed time once accepted.

Who Should Choose Elite Trader Funding

- Futures-specialized traders. If you exclusively trade futures (ES, NQ, MES, MNQ, GC, CL, etc.), Elite's infrastructure is purpose-built for your instrument class. DNA's CFD futures contracts are a workaround, not a solution.

- Traders chasing rapid capital access with aggressive profit-sharing. Elite's 100% profit split on the first $12,500 in gains is structurally superior for early payouts. If you can consistently generate $12,500 in sim-funded profits, Elite's tier structure rewards you immediately.

- Scalpers and news traders. Elite explicitly allows news trading without minimum trading day requirements on select plans. If your edge depends on macroeconomic data releases or earnings announcements, Elite accommodates this; DNA's stance is unclear.

- Budget-conscious traders (during promotions). Elite's frequent 50–90% discounts on evaluation fees make initial challenge costs extremely low—sometimes under $15. If you're evaluating multiple prop firms or capital-constrained, these promotions are genuine savings, even if long-term costs are higher.

The Verdict, Plainly

DNA Funded wins for traders who want multi-asset exposure, regulatory legitimacy, and long-term cost efficiency. Elite Trader Funding wins for futures-specialized traders who can achieve consistent payouts quickly and are willing to pay premium ongoing costs for aggressive profit-sharing structures.

Choose DNA Funded if you trade forex, CFDs, crypto, or multiple asset classes, or if regulatory backing and low long-term costs drive your decision. Choose Elite Trader Funding if you're a pure-play futures trader, can exploit news trading edges, and want to maximize early profit retention rather than minimize monthly fees. The $49 vs. $155 monthly cost gap ($792/year) represents DNA's clearer value proposition—Elite must deliver measurably faster profitability to justify its premium.